
Meowsprout Therapeutics, formerly GeniusHealth, is a digital medicine company focused on AI-empowered child developmental assistance for behavioral and neuro-disorders such as ADHD and ASD. The company integrates VR, sensing, and perception technologies to capture physiological signals for AI-enabled assessment, diagnosis, and intervention, aiming to improve clinical outcomes. Their platform connects online and offline patient-centered solutions to empower communities. With a strong scientific and clinical team, Meowsprout is advancing multiple clinical trials and regulatory approvals in Asia and North America, targeting a growing global ADHD therapeutics market. Their technology boasts high diagnostic accuracy and significant treatment improvement rates, positioning them for immediate revenue generation and market impact.

Meowsprout Therapeutics, formerly GeniusHealth, is a digital medicine company focused on AI-empowered child developmental assistance for behavioral and neuro-disorders such as ADHD and ASD. The company integrates VR, sensing, and perception technologies to capture physiological signals for AI-enabled assessment, diagnosis, and intervention, aiming to improve clinical outcomes. Their platform connects online and offline patient-centered solutions to empower communities. With a strong scientific and clinical team, Meowsprout is advancing multiple clinical trials and regulatory approvals in Asia and North America, targeting a growing global ADHD therapeutics market. Their technology boasts high diagnostic accuracy and significant treatment improvement rates, positioning them for immediate revenue generation and market impact.